Neurocrine Biosciences | 当期純利益



Net Income 変化する 日付
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Dynavax Technologies USD -96099000 103.15M 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Gilead Sciences USD 1.78B 529M 2024-12
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prothena USD -57956000 1.04M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Repligen USD 5.83M 39.7M 2025-03
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Neurocrine Biosciences 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.